privacy | investment disclaimer | contact us
Excorp Medical's Bioartificial Liver System comprises a reusable instrument, disposable tubing set and the proprietary, disposable bioartificail reactor.Once approved by regulatory agencies, Excorp Medical expects this breakthrough Bioartificial Liver System technology to be both live-saving and cost effective.Certain drugs or machines are available to substitute temporarily or long-term for many organs in the body…  no comparable substitute has been developed for the liver.The liver is the largest organ in the body and performs a variety of tasks impacting all body systems… as a result liver disease has widespread effects on virtually all other organs.Excorp Medical is currently the only company approved to conduct bioartificial liver human trials within the U.S.Currently patients must receive a liver transplant or endure prolonged hospitalization at great expense to have a chance at survival.Excorp Medical Bioartificial Liver System treatments serve as a bridge to liver regeneration and transplantExcorp Medical has developed a Bioartificial Liver System for the metabolic support of patients with compromised liver function.
Chinese Simplified
简体中文
Chinese Traditional
繁體中文
Arabic
Click below for
more info...
MOFCOM Summary
Mar 2009

Download

Executive Summary
Jan 2009

Download

Excorp Medical
Brochure

Download

US FDA's Orphan
Drug Benefits

Download

Investors


Excorp Medical, Inc., established November 22, 1995, is a Corporation headquartered and registered in the state of Minnesota in the US. The near term goal of Excorp Medical, Inc. and its entities is to provide a profitable, cost effective, temporary liver assist system for patients in acute liver failure supporting a patient’s own liver regeneration or until a liver transplant can be performed.

The information on this web site is provided for informational purposes only, is not comprehensive, does not contain important disclosures and risk factors associated with an Excorp Medical, Inc. investment, and is subject to change without notice.

No information contained in any part of this web site is an offer to buy or sell or a solicitation of an offer to buy or sell an investment in Excorp Medical, Inc. If any offer to invest is made, it shall be pursuant to a definitive Private Placement Memorandum prepared by or on behalf of Excorp Medical, Inc. which would contain material information not contained herein and which shall supersede this information in its entirety.

Any decision to invest in Excorp Medical, Inc. should be made after reviewing the definitive Private Placement Memorandum, conducting such investigations as the investor deems necessary and consulting the investor’s own investment, legal, accounting, and tax advisors in order to make an independent determination of the suitability and consequences of an investment in Excorp Medical, Inc.

Contact Excorp Medical, Inc. for further information.


news
affiliates
publications
clinical trials
careers
investors
links & resources
©2014 Excorp Medical, Inc.